Checkpoint Inhibitors as High-Grade Gliomas Treatment: State of the Art and Future Perspectives.

Persico, Pasquale; Lorenzi, Elena; Dipasquale, Angelo; Pessina, Federico; Navarria, Pierina; Politi, Letterio S; Santoro, Armando; Simonelli, Matteo

Persico, Pasquale; Lorenzi, Elena; Dipasquale, Angelo; Pessina, Federico; Navarria, Pierina; Politi, Letterio S; Santoro, Armando; Simonelli, Matteo.

Afiliação

Persico P; Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20090 Milan, Italy.
Lorenzi E; Oncology Department, IRCCS Humanitas Research Hospital, via Manzoni 56, 20089 Milan, Italy.
Dipasquale A; Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20090 Milan, Italy.
Pessina F; Oncology Department, IRCCS Humanitas Research Hospital, via Manzoni 56, 20089 Milan, Italy.
Navarria P; Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20090 Milan, Italy.
Politi LS; Oncology Department, IRCCS Humanitas Research Hospital, via Manzoni 56, 20089 Milan, Italy.
Santoro A; Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20090 Milan, Italy.
Simonelli M; Neurosurgery Department, IRCCS Humanitas Research Hospital, via Manzoni 56, 20089 Milan, Italy.

J Clin Med ; 10(7)2021 Mar 26.

Article em En | MEDLINE | ID: mdl-33810532

Palavras-chave

PD-1; PD-L1; checkpoint inhibitors; glioblastoma; glioma; immunotherapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Clin Med Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Itália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google